MedPath

REDESCA

REDESCA

Approved
DIN Number

02509105

Drug Class

Human

Market Date

Apr 9, 2021

Company
HC

Shenzhen Techdow Pharmaceutical Co., Ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02509105
AIG Number0131860001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AB05 ENOXAPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Subcutaneous
AHFS Classification20:12.04.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

ENOXAPARIN SODIUMActive
Strength: 80 MG / 0.8 ML
Monograph: ENOXAPARIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.